In clinical trials
Sexual & reproductive
Kisspeptin-10
Evidence
Early clinical research
Class
Fragment of kisspeptin
KEY TAKEAWAY
Kisspeptin-10 is a short fragment of the kisspeptin hormone that triggers release of GnRH. It is being studied in early trials for fertility treatment and is not approved.
Written by the Veylo editorial team · Updated
November 2026
What it is
A fragment of the hormone that triggers reproductive signaling
Studied for
Fertility treatment and reproductive hormone disorders
Key fact
Stimulated reproductive hormone release in early human studies
Route
Injection (investigational)
Evidence strength
Early clinical research
Kisspeptin-10 is a ten-amino-acid active region of kisspeptin, a brain hormone that controls the reproductive axis.
It stimulates GnRH neurons, which signal the pituitary to release hormones that drive ovulation and testosterone production.
Kisspeptin-10 is not approved by the FDA. It is used only in research settings.
Investigated for infertility, including triggering egg maturation, and for hormone disorders.
Short-term injections were well tolerated in small studies. Long-term effects are unknown.
Primary literature for this entry is being compiled.
Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.